Janus Henderson Group’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Janus Henderson Group’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.4M	Buy	2,362,696 +2,360,957	+135,765%	+$60.7M	0.03%	368
2025 Q4	$40M	Buy	+1,739	New	+$30.2K	0.02%	455
2022 Q2	–	Sell	-28,981	Closed	-$1.59M	–	2631
2022 Q1	$1.59M	Sell	28,981 -1,409	-5%	-$79.1K	﹤0.01%	1311
2021 Q4	$2.3M	Sell	30,390 -21,050	-41%	-$1.65M	﹤0.01%	1229
2021 Q3	$4.5M	Sell	51,440 -540	-1%	-$57.7K	﹤0.01%	1082
2021 Q2	$6.41M	Sell	51,980 -897	-2%	-$122K	﹤0.01%	1012
2021 Q1	$7.83M	Sell	52,877 -546	-1%	-$149K	﹤0.01%	937
2020 Q4	$15.9M	Buy	+53,423	New	+$19.9M	0.01%	790

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCP

Remedium Capital Partners Fort Lauderdale, Florida $281M AUM

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group's DMRA Position: Q1 2026 in Review

Janus Henderson Group increased its Damora Therapeutics, Inc. Ordinary Shares (DMRA) stake by 135,765% in Q1 2026, buying an estimated $60.7M and bringing the position to 2,362,696 shares worth $61.4M. The position accounts for 0.03% of the portfolio, ranked #368.

Janus Henderson Group first reported a position in DMRA in Q4 2020 and has held it in 8 quarters since. 65 funds tracked by Wall St. Rank hold DMRA as of Q1 2026.

Janus Henderson Group held 2,362,696 shares of Damora Therapeutics, Inc. Ordinary Shares worth $61.4M as of Q1 2026.
Janus Henderson Group bought 2,360,957 Damora Therapeutics, Inc. Ordinary Shares shares in Q1 2026, an estimated $60.7M.
Damora Therapeutics, Inc. Ordinary Shares made up 0.03% of Janus Henderson Group's portfolio in Q1 2026, its #368 holding.
Janus Henderson Group first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q4 2020 and has held it in 8 quarters since.
65 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.